| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2082631 | Drug Discovery Today: Technologies | 2013 | 6 Pages |
Abstract
The zebrafish is increasingly being adopted as an in vivo model of high throughput drug screening. In this brief review we outline the advantages and disadvantages of this approach and summarize recent screens that have attempted to identify novel small molecules with activity on the cardiovascular system.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Peter Novodvorsky, Marc M.J. Da Costa, Timothy J.A. Chico,